Source: SKS Technologies [LinkedIn]
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • SKS Technologies Group (SKS) has received a formal acceptance of approximately $10 million to supply the audio visual package for the new Footscray Hospital, in Melbourne
  • It is to design, supply and install the Audio-Visual package related to the Private Public Partnership for the hospital
  • Construction of the $1.5 billion new Footscray Hospital is now underway
  • Matthew Jinks, CEO of SKS Technologies, says this formal acceptance is a significant achievement for the company
  • SKS Technologies Group Limited (SKS) last traded at $0.18 per share before market open on December 23

SKS Technologies Group (SKS) has received a formal acceptance of approximately $10 million to supply the audio visual package for the new Footscray Hospital, in Melbourne.

Construction of the $1.5 billion new Footscray Hospital is now underway, with SKS chosen to design, supply and install the Audio-Visual package related to the Private Public Partnership for the hospital.

The hospital will be the largest ever health infrastructure investment in Victoria’s history and is due to be completed in 2025.

Additional infrastructure will allow 15,000 more patients to be treated and almost 20,000 extra people to be seen in the emergency department each year.

There will also be a significant increase in mental health beds and more outpatient, palliative care, and surgical services.

Matthew Jinks, CEO of SKS Technologies, said this formal acceptance is a significant achievement for the company.

“Upon execution of the contract, expected to be in the early part of next year, the contract will place the company’s work in hand position in excess of $40 million and provides the business with a strong foundation for future growth and profits,” he said.

SKS Technologies Group Limited (SKS) last traded at $0.18 per share before market open on December 23.

SKS by the numbers
More From The Market Online
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…